Skip to main content
OpenTrials

Clinical trial condition

Hypophosphatemia, Familial

Explore clinical trials studying Hypophosphatemia, Familial. Study availability and eligibility vary by location and protocol.

38 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Hypophosphatemia, Familial trial results

Recruiting

A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

NCT06525636

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +30 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Yale Center for XLH/ Yale University School of Medicine New Haven, Connecticut, United States
  • Indiana University School of Medicine University Hospital Indianapolis, Indiana, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Not Yet Recruiting

Treatment Patterns, Biochemical Profiles and Clinical Outcomes in Adults With X-Linked Hypophosphatemia

NCT07607600

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Indiana University Hospital Indianapolis, Indiana, United States
  • The Ohio State University Wexner Medical Center (OSUWMC) - CarePoint East Columbus, Ohio, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View all 23 locations
View Trial Details
Completed

A Study to Describe the Lived Experience of XLH for Adolescents at End of Skeletal Growth

NCT05181839

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • Centre Hospitalier Universitair de Lille Lille, France
  • Hospices Civils De Lyon Lyon, France
  • APHP Paris - Assistance Publique Hopitaux de Paris Paris, France
  • Charité - Universitätsmedizin Berlin Berlin, State of Berlin, Germany
View all 14 locations
View Trial Details
Completed

Baby Detect : Genomic Newborn Screening

NCT05687474

Conditions
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations
  • CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
View Trial Details
Completed

Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age

NCT04188964

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • Kepler Universitaetsklinikum GmbH Linz, Austria
  • Centre de reference des maladies renales rares-Hospices Civils de Lyon-Hopital Femme Mere Enfant Lyon, France
  • Hopital Kremlin APHP Paris, France
  • Ospedale Pediatrico Bambino Gesù Rome, Italy
View Trial Details
Completed

Efficacy and Safety of Burosumab Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With XLH

NCT02915705

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • Shriners Hospital For Children St Louis, Missouri, United States
View all 16 locations
View Trial Details
Completed

A UK Multicentre, Health-Related Quality of Life Study for Children and Adolescents With XLH

NCT04819490

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • Royal Hospital for Sick Children Edinburgh, United Kingdom
  • NHS Greater Glasgow & Clyde- South Glasgow University Hosp Division Glasgow, United Kingdom
  • Leeds Teaching Hospitals NHS Trust, Trust Headquarters, St. James's University Hospital Leeds, United Kingdom
  • Evelina Childrens Hospital London, United Kingdom
View Trial Details

Related conditions